Infect Chemother. 2010 Aug;42(4):244-248. Korean.
Published online Aug 30, 2010.
Copyright © 2010 by The Korean Society of Infectious Diseases and Korean Society for Chemotherapy
Case Report

A Case of Disseminated Aspergillosis Presenting Solely as Multiple Cutaneous Lesions in an Acute Leukemia Patient

Jin-Hee No, Jin-Sok Yu, Eun-Ok Kim, Hyun-Ho Choi, Si-Hyun Kim, Jae-Cheol Kwon, Dong-Gun Lee, Su-Mi Choi, Sun-Hee Park, Jung-Hyun Choi, Jin-Hong Yoo, Hee-Je Kim and Woo-Sung Min
    • Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Received January 12, 2010; Revised July 03, 2010; Accepted July 05, 2010.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Invasive aspergillosis (IA) is a major cause of morbidity and mortality in patients with hematological malignancies. While the development of new effective antifungals and advancement of diagnostic techniques have lead to improved outcomes, relapse of IA in patients with subsequent immunosuppression is emerging as a major issue. The primary IA site is the most common relapse site, but disseminated infection from the lung to multiple organs, including the brain, thyroid, liver, spleen, kidney, bone, heart valve, and skin, can often occur in patients with severe immunosuppression. Furthermore, relapsing or disseminated IA have very poor outcomes. We report a case of disseminated IA presenting as multiple cutaneous lesions without involvement of any other organs in an acute leukemia patient. The patient had suffered from prior invasive pulmonary aspergillosis, which was treated successfully. The multiple skin lesions were fully resolved after antifungal therapy for 6 weeks.

Keywords
Cutaneous aspergillosis; Disseminated aspergillosis; Acute myeloid leukemia

Figures

Figure 1
Photograph of the patient showing an erythema surrounding central necrotic eschar on the left forearm.

Figure 2
Punch biopsied specimen of skin shows acute and chronic inflammation with hyaline, septated, and acute-angle branched hyphae invading vessels in dermis and subcutis (A) Periodic acid Schiff (H&E stain, ×400), (B) Grocott-Gomori methenamine silver (H&E stain, ×400).

References

    1. Mandell GL, Bennett JE, Dolin R. In: Principles and Practice of Infectious Diseases. 6th ed. Philadelphia: Elsevier Churchill Livingstone; 2005. pp. 3495.
    1. Maschmeyer G, Haas A, Cornely OA. Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients. Drugs 2007;67:1567–1601.
    1. Lass-Flörl C. The changing face of epidemiology of invasive fungal diseases in Europe. Mycoses 2009;52:197–205.
    1. Yoo JH, Choi JH, Lee DG, Choi S, Shin WS, Kim CC. Analysis of invasive fungal infection after hematopoietic stem cell transplantation or chemotherapy in patients with hematologic diseases. Infect Chemother 2004;36:40–45.
    1. Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001;32:358–366.
    1. Park SH, Choi SM, Lee DG, Choi JH, Yoo JH, Lee JW, Min WS, Shin WS, Kim CC. Current trends of infectious complications following hematopoietic stem cell transplantation in a single center. J Korean Med Sci 2006;21:199–207.
    1. van Burik JA, Colven R, Spach DH. Cutaneous aspergillosis. J Clin Microbiol 1998;36:3115–3121.
    1. Seo JK, Chun JS, Seol JE, Choi JH, Hwang SW, Sung HS, Lee D. A case of invasive aspergillosis with skin involvement in a renal transplant recipient. Korean J Dermatol 2009;47:1190–1192.
    1. Park JH, Lee YJ, Park SH, Choi SY, Lee MS, Kim JH, Park SK. Disseminated aspergillosis with cutaneous aspergillosis and aspergergillus thyroiditis in a renal allograft recipient. Korean J Med 2001;60:85–91.
    1. Kim YS, Kim SM, Peck KR, Cho SU, Shin HS, Bae HJ, Woo JH, Song YW, Choe GW. Clinical study on invasive aspergillosis. Korean J Intern Med 1990;38:526–538.
    1. D'Antonio D, Pagano L, Girmenia C, Parruti G, Mele L, Candoni A, Ricci P, Martino P. Cutaneous aspergillosis in patients with haematological malignancies. Eur J Clin Microbiol Infect Dis 2000;19:362–365.
    1. Hope WW, Walsh TJ, Denning DW. The invasive and saprophytic syndromes due to Aspergillus spp. Med Mycol 2005;43 Suppl 1:207–238.
    1. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Muñoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE. European Organization for Research and Treatment of Cancer/Invasive Fungal Infect ions Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Revised definitions of invasive fungal disease from the European Organization for research and treatment of cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC/MSG) consensus group. Clin Infect Dis 2008;46:1813–1821.
    1. Cornely OA, Böhme A, Reichert D, Reuter S, Maschmeyer G, Maertens J, Buchheidt D, Paluszewska M, Arenz D, Bethe U, Effelsberg J, Lövenich H, Sieniawski M, Haas A, Einsele H, Eimermacher H, Martino R, Silling G, Hahn M, Wacker S, Ullmann AJ, Karthaus M, Multinational Case Registry of the Infectious Diseases Working Party of the German Society for Hematology and OncologyRisk factors for breakthrough invasive fungal infection during secondary prophylaxis. J Antimicrob Chemother 2008;61:939–946.
    1. Sipsas NV, Kontoyiannis DP. Clinical issues regarding relapsing aspergillosis and the eff icacy of secondary antifungal prophylaxis in patients with hematological malignancies. Clin Infect Dis 2006;42:1584–1591.
    1. Upton A, Kirby KA, Carpenter P, Boeckh M, Marr KA. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis 2007;44:531–540.
    1. Fukuda T, Boeckh M, Guthrie KA, Mattson DK, Owens S, Wald A, Sandmaier BM, Corey L, Storb RF, Marr KA. Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center. Biol Blood Marrow Transplant 2004;10:494–503.
    1. Offner F, Cordonnier C, Ljungman P, Prentice HG, Engelhard D, De Bacquer D, Meunier F, De Pauw B. Impact of previous aspergillosis on the outcome of bone marrow transplantation. Clin Infect Dis 1998;26:1098–1103.
    1. Bae KS, Park JY, Shin SY, Mun YC, Choi HJ, Cho MS, Seong CM. Disseminated aspergillosis following allogeneic hematopoietic stem cell transplantation in an acute leukemic patient who was previously treated for invasive aspergillosis. Infect Chemother 2003;35:221–225.
    1. Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Segal BH, Steinbach WJ, Stevens DA, van Burik JA, Wingard JR, Patterson TF. Infectious Diseases Society of America. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008;46:327–360.

Metrics
Share
Figures

1 / 2

PERMALINK